[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Re: Alma Swan: The OA citation advantage
- To: liblicense-l@lists.yale.edu
- Subject: Re: Alma Swan: The OA citation advantage
- From: Stevan Harnad <amsciforum@gmail.com>
- Date: Wed, 17 Mar 2010 21:54:56 EDT
- Reply-to: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
On Mon, Mar 15, 2010 at 9:53 PM, Philip Davis <pmd8@cornell.edu> wrote: > Stevan, > > First of all, I did not state in my critique of the Swan report > (http://j.mp/d91Jk2) that meta-analysis was Alma's idea, but that > this was your suggestion (as posted to liblicense-l, > sigmetrics-l, and other listservs). > > Secondly, you keep trying to divert criticism of your > colleague's work by critiquing my own work, as if *"your best > defense is a good offense."* You've posted 5 rapid responses > to the BMJ 2008 paper and another rapid response to the BMJ > editorial. > [http://www.bmj.com/cgi/eletters/337/jul31_1/a568#top ] I've > responded to your concerns and have better things to do than > engage in an endless discussion with you when there is > absolutely no hope of changing your mind. You can continue to > plaster the Internet with your critiques and astonishment that > I haven't responded if this makes you feel better. I have > students to teach and a dissertation to write. > > --Phil Davis The message below is forwarded from David Wilson, with permission [references and links added]: [See also (thanks to Peter Suber for spotting this study!): Wagner, A. Ben (2010) Open Access Citation Advantage: An Annotated Bibliography. Issues in Science and Technology Librarianship. 60. Winter 2010 http://www.istl.org/10-winter/article2.html] ****************** Date: March 17, 2010 11:17:10 AM EDT (CA) From: David Wilson dwilsonb -- gmu.edu Subject: Re: Comment on Meta-Analysis To: harnad -- ecs.soton.ac.uk Stevan, Interesting discussion. Phil Davis has a limited albeit common view of meta-analysis. [http://bit.ly/bCKzWk] Within medicine, meta-analysis is generally applied to a small set of highly homogeneous studies. As such, the focus is on the overall or pooled effect with only a secondary focus on variability in effects. Within the social sciences, there is a strong tradition of meta-analyzing fairly heterogeneous sets of studies. The focus is clearly not on the overall effect, which would be rather meaningless, but rather on the variability in effect and the study characteristics, both methodological and substantive, that explain that variability. I don't know enough about this area to ascertain the credibility of his criticism of the methodologies of the various studies involved. However, the one study that he claims is methodologically superior in terms of internal validity (which it might be) [http://www.bmj.com/cgi/content/full/337/jul31_1/a568] is clearly deficient in statistical power. As such, it provides only a weak test. Recall, that a statistically nonsignificant finding is a weak finding -- a failure to reject the null and not acceptance of the null. Meta-analysis could be put to good use in this area. It won't resolve the issue of whether the studies that Davis thinks are flawed are in fact flawed. It could explore the consistency in effect across these studies and whether the effect varies by the method used. Both would add to the debate on this issue. [Lipsey, MW & Wilson DB (2001) Practical Meta-Analysis. Sage.] Best, Dave David B. Wilson, Ph.D. Associate Professor Chair, Administration of Justice Department George Mason University Manassas, VA 20110-2203 dwilsonb@gmu.edu http://mason.gmu.edu/~dwilsonb/home.html ---2071850956-272186185-1268877205=:22091--
- Prev by Date: Re: Does free lead to paid?
- Next by Date: Upcoming ALCTS webinars
- Previous by thread: Re: Alma Swan: The OA citation advantage
- Next by thread: FINAL REMINDER: Online Certificate - Copyright Management and Leadership - Register Today
- Index(es):